Lauren Duvall
Psychiatric/Mental Health · Toledo, OHNPI 1952801078
Payments from drug & device makers
Across 248 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$464
- Otsuka America Pharmaceutical, Inc.$449
- Neurocrine Biosciences, Inc.$382
- Axsome Therapeutics, Inc.$358
- AbbVie$356
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$355
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,030100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 32 | $464 |
| Otsuka America Pharmaceutical, Inc. | 31 | $449 |
| Neurocrine Biosciences, Inc. | 21 | $382 |
| Axsome Therapeutics, Inc. | 12 | $358 |
| AbbVie | 25 | $356 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $355 |
| Lundbeck LLC | 25 | $327 |
| Teva Pharmaceuticals USA, Inc. | 20 | $326 |
| Johnson & Johnson | 7 | $132 |
| Indivior Inc. | 7 | $118 |
| E.r. Squibb & Sons, L.L.C. | 7 | $117 |
| Corium, LLC | 6 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $90 |
| Ironshore Pharmaceuticals Inc. | 4 | $72 |
| Luye Pharma (USA) Ltd. | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 4 | $62 |
| Tris Pharma Inc | 4 | $59 |
| Bioxcel Therapeutics, Inc. | 1 | $56 |
| Sage Therapeutics, LLC | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Avion Pharmaceuticals | 1 | $16 |
| Convatec Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$125
How this compares
$4,030 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $126,078 |
| Invega SustennaPaliperidone Palmitate | 19 | $63,664 |
| VraylarCariprazine Hcl | 32 | $48,246 |
| RexultiBrexpiprazole | 13 | $37,675 |
| CaplytaLumateperone Tosylate | 12 | $21,285 |
| TrintellixVortioxetine Hydrobromide | 33 | $20,762 |
| Paliperidone ErPaliperidone | 29 | $9,360 |
| VyvanseLisdexamfetamine Dimesylate | 20 | $7,219 |
| Divalproex Sodium ErDivalproex Sodium | 50 | $4,436 |
| Quetiapine Fumarate | 147 | $3,813 |
| Lurasidone Hcl | 42 | $3,811 |
| Atomoxetine Hcl | 48 | $3,789 |
| Aripiprazole | 69 | $3,599 |
| Lisdexamfetamine Dimesylate | 17 | $2,776 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 66 | $2,059 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $382 | $126,07813 claims |
| Johnson & JohnsonInvega Sustenna | $132 | $63,66419 claims |
| AbbVieVraylar | $356 | $48,24632 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $449 | $37,67513 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $90 | $27,98153 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $355 | $21,28512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Toledo
- Christine MillerToledo$12K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.